drugset
drugset / Trial / NCT00663065

A Study of the Safety of PAZ-417 in Healthy Elderly Adults

NCT00663065 ↗

Phase 1 Terminated 40 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedSingle-groupDouble-blindTreatment

Summary

This is study to determine the safety of PAZ-417 in healthy adults over 65.

Timeline

Start
2008-04
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ALEPLASININ Small molecule — Oral

Indications

No indication recorded.